Erik Harris - Insider Trading & Ownership

Entity
Individual
Location
60 Leveroni Court, Novato, CA
Summary
The estimated net worth of Erik Harris is at least $3.96M dollars as of October 7, 2024. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $3.61M. Erik Harris is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $348K.
All Insider Reports
All Insider Reports

Ownership of Erik Harris

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RARE Ultragenyx Pharmaceutical Inc. EVP & Chief Commercial Officer $3.61M -$256K -6.63% Mar 1, 2024
DNLI Denali Therapeutics Inc. Director $348K May 31, 2024
INZY Inozyme Pharma, Inc. Director Oct 3, 2024

Insider Transactions Reported by Erik Harris:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.